Skip to content

13F-HR filed by New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 12 holding rows worth $124,150,221.

Accession
0000950123-24-002003
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 12 entries on the cover page, a total value of $124,150,221 stated on the cover page (in dollars after the unit check, H1), rows summing to $124,150,221 with VALUE read as dollars as filed, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARVINAS INC04335A105COM1,289,521$53,076,684dollars as filed
HARPOON THERAPEUTICS INC41358P106COM1,859,168$21,138,740dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM1,553,661$16,997,051dollars as filed
DECIPHERA PHARMACEUTICALS IN24344T101COM576,975$9,306,607dollars as filed
RALLYBIO CORP75120L100COM3,301,603$7,890,831dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock141,000$5,016,780dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM118,242$3,543,713dollars as filed
ALECTOR INC014442107COMMON STOCK339,569$2,709,761dollars as filed
PASSAGE BIO INC702712100COM2,497,922$2,522,901dollars as filed
COGENT BIOSCIENCES INC19240Q201COM250,765$1,474,498dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM335,000$281,400dollars as filed
ITERUM THERAPEUTICS PLCG6333L200COM97,084$191,255dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-002003this filing2024-02-14acceptance time not in the bulk data set